Affiliation:
1. International Cooperation Section, Ministry of Ayush, Government of India, New Delhi, India
2. Department of Research, Government Yoga and Naturopathy Medical College, Chennai, Tamil Nadu, India
3. Department of Naturopathy, Government Yoga and Naturopathy Medical College, Chennai, Tamil Nadu, India
Abstract
Abstract
Background Chronic heart failure (CHF) is a prevalent cardiovascular condition that can significantly impact the quality of life and increase mortality risk. Yoga is a mind–body therapy that has been studied as a potential complementary treatment for CHF. However, the effectiveness of yoga in improving outcomes in patients with CHF remains uncertain.
Methods We conducted a systematic review of randomized controlled trials (RCTs) evaluating the effects of yoga on outcomes in patients with CHF. We searched the PubMed, Embase, Scopus, Cochrane Library, and IndMED databases from inception to March 2023. The outcomes of interest were left ventricular ejection fraction (LVEF), cardiac biomarkers, exercise capacity, quality of life, and cardiac function.
Results We identified 11 RCTs that met our inclusion criteria, involving a total of 552 participants. The meta-analysis showed that yoga was associated with significant improvements in peak VO2 (mean difference [MD]= 3.29; 95% Confidence Interval [CI]: 1.64 to 4.94; I2 = 0%), exercise capacity (MD=101.54; 95% CI: 6.24 to 196.83; I2 = 96%), quality of life (MD = –19.99; 95% CI: –25.76 to –14.22; I
2 = 43%), NT-proBNP (MD = –288.78; 95% CI: –492.20 to –85.37; I
2 = 94%), and 6-minute walk test (MD = 101.54; 95% CI: 6.24–196.83; I
2 = 96%), but not in the left ventricular ejection fraction (MD = 4.28; 95% CI: –1.14 to 9.70; I
2 = 93%). Subgroup analysis suggested that the effect of yoga on the quality of life is more pronounced in patients with the “New York Heart Association” (NYHA) class I and II CHF patients and in those who practiced yoga for longer durations. No serious adverse events related to yoga were reported. Most of the included studies were of “low” quality.
Conclusion Current evidence suggests that yoga may be an effective complementary and integrative therapy for improving peak VO2 exercise capacity, NT-proBNP, and quality of life in patients with CHF. However, the low-quality evidence does not render us to conclude anything beyond doubt or draw any firm clinical recommendation. Future high-quality studies are needed to explore the optimal duration and frequency of yoga practice and its effects on long-term outcomes in this population.
Reference25 articles.
1. Epidemiology of heart failure;V L Roger;Circ Res,2013
2. Epidemiology of heart failure in Asia;Y Sakata;Circ J,2013
3. Worldwide risk factors for heart failure: a systematic review and pooled analysis;S Khatibzadeh;Int J Cardiol,2013
4. Effect of yoga therapy on heart rate, blood pressure and cardiac autonomic function in heart failure;B H Krishna;J Clin Diagn Res,2014
5. Yoga in heart failure patients: a pilot study;J Howie-Esquivel;J Card Fail,2010
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献